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Abstract 
CONTEXT: 
Unbalanced subtelomeric chromosomal rearrangements are often associated with intellectual 
disability (ID) and malformation syndromes. The prevalence of such rearrangements has been 
reported to be 5-9% in ID populations. 
AIMS: 
To study the prevalence of subtelomeric rearrangements in the Indonesian ID population. 
MATERIALS AND METHODS: 
We tested 436 subjects with unexplained ID using multiplex ligation dependent probe 
amplification (MLPA) using the specific designed sets of probes to detect human 
subtelomeric chromosomal imbalances (SALSA P070 and P036D). If necessary, abnormal 
findings were confirmed by other MLPA probe kits, fluorescent in situ hybridization or Single 
Nucleotide Polymorphism array. 
RESULTS: 
A subtelomeric aberration was identified in 3.7% of patients (16/436). Details on 
subtelomeric aberrations and confirmation analyses are discussed. 
CONCLUSION: 
This is the first study describing the presence of subtelomeric rearrangements in individuals 
with ID in Indonesia. Furthermore, it shows that also in Indonesia such abnormalities are a 
prime cause of ID and that in developing countries with limited diagnostic services such as 
Indonesia, it is important and feasible to uncover the genetic etiology in a significant number 
of cases with ID. 
Keywords: Indonesia, intellectual disability, multiplex ligation dependent probe 
amplification, subtelomeric rearrangements 
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Introduction 
The genetic causes of intellectual disability (ID) comprise (sub) microscopically chromosome 
abnormalities and monogenic diseases.[1] Microscopically visible numerical and structural 
abnormalities are the most common cause of ID. In a large meta-analysis review, a median 
rate of 9.5% was described.[2] Apart from these microscopically visible chromosomal 
abnormalities, there are submicroscopic abnormalities that cannot be detected by conventional 
karyotyping. Abnormalities in the most distal ends of chromosomes, which harbor the highest 
gene concentrations in the human genome,[3] are difficult to identify on routine chromosome 
analysis while they represent an important genetic cause of idiopathic ID. Therefore, testing 
for such rearrangements has turned out to be an important clinical evaluation step in the 
etiological diagnosis of unexplained ID cases.[4] In several studies, subtelomeric 
rearrangements were found to be associated with moderate to severe phenotypic abnormalities 
and turned out to be a significant cause of ID, with an estimated prevalence of 5-9% of cases 
in various populations.[5–7] To date, however, there are no data about the prevalence of 
subtelomeric rearrangements in Indonesia. 
In a large number of Indonesian ID patients, the cause of ID could be established by 
conventional karyotyping or molecular testing for fragile X syndrome (FXS), but the majority 
of cases still remained unexplained.[8] Therefore, this study aimed at determining the 
prevalence of subtelomeric rearrangements and the clinical features in these ID individuals in 
Indonesia. 
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Materials and Methods 
This research is an extension of previously reported studies on the identification of genetic 
causes of ID in Indonesia, where chromosomal aberrations and FXS were investigated in a 
large cohort of 527 Indonesian ID individuals from several special schools and institutions in 
Java Island, Indonesia. These previous studies revealed chromosomal abnormalities in 82 
individuals and FXS in 9 individuals.[8,9] In the present study, molecular testing of 
subtelomeric deletions and duplications was performed in the 436 as yet unresolved patients 
(278 males and 158 females). Informed consent was obtained from the parents or legal 
representatives, and the study has been approved by the Ethical Board of our institute. All 
subjects underwent a standardized clinical examination including physical measurements and 
dysmorphological assessment. 
The DNA was isolated from peripheral blood using the salting out extraction procedure as 
described elsewhere.[10] Multiplex ligation dependent probe amplification (MLPA) analysis 
was performed as described previously.[11] Two probe-kits for subtelomeric chromosomal 
imbalances were used in these experiments: SALSA P070 and SALSA P036D MRC-Holland, 
Amsterdam, The Netherlands (http://www.mrc-holland.com). Each subtelomeric 
rearrangement was identified by at least one additional MLPA analysis using the SALSA 
P070 as the first level screening. Afterwards, SALSA P036D was utilized for confirmation of 
the aberration detected with the P070 kit. Rearrangements in specific regions were verified 
with SALSA kit P028, P023B, P340A or P096. The detail of regions detected by each kit is 
available at http://www.mlpa.com. Amplification products were identified and quantified by 
capillary electrophoresis on an ABI 3730 genetic analyzer (Applied Biosystems, Foster City, 
CA, USA) using GeneMapper Software version 3.7 (Apache Software; 
http://www.apache.org), manufacturer (University of Tokyo). Statistical analyses were carried 
out using Microsoft®Excel spreadsheets as described before.[12] The results were considered 
abnormal when the relative peak height ratio was below 0.70 or above 1.30. 
When a deletion or duplication was detected in both MLPA kits, parents were tested for de 
novo occurrence. When parental DNA was not available, additional methodologies were 
performed for confirmation of the presence of the detected deletion or duplication. 
Fluorescence in situ hybridization (FISH) analysis was performed using commercially 
available probes (Vysis, Inc., Downers Grove, IL, USA) according to the manufacturer’s 
recommendations. Single Nucleotide Polymorphism (SNP) array analyses were performed 
using the Affymetrix NspI 250K SNP array platform (www.Affymetrix.com). Copy number 
estimates were determined using the Copy Number Analyzer for Affymetrix Genechip 
Mapping (CNAG) software package version 2 (http://www.genome.umin.jp/), manufacturer 
(University of Tokyo).[13] 
The clinical data of all patients were reviewed and compared to other cases with a comparable 
aberration, described in the literature. 
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Results 
The initial screening with the SALSA P070 probe kit showed a subtelomeric deletion and/or 
duplication in 23 of the 436 ID individuals [Table 1]. In 20 of these samples, the presence of 
the aberration could be confirmed by the SALSA P036D kit [cases 1-20, Table 1, while in the 
three remaining cases, this was not possible and they were considered to be either artefacts or 
non-causative variants. Parental testing was possible in eight of the 20 cases (cases 1-8) and 
revealed a de novo occurrence of the subtelomeric imbalances in five cases (cases 1-4 and 6). 
These five aberrations were, therefore, considered being pathogenic [Tables [Tables11 and 
and2].2]. The phenotypes of cases 1 and 2 share many similarities with known cases with 
monosomy 18pter[14] or a subtelomeric duplication of 9p24,[15] respectively. In cases 3, 4, 
and 5, a subtelomeric deletion appeared to be coexistent with a subtelomeric duplication, 
which implicates the presence of a cryptic unbalanced translocation. The phenotype of case 3 
was comparable to reported cases with either a 4p duplication[14] or a 18p deletion.[16] 
Therefore, either dup 4pter or deletion 18pter (or both) could be contributing to the phenotype 
in the case 3. In case 4, the phenotype is most likely due to the deletion of 10pter, because of 
the phenotypic overlap with previously reported cases with a deletion of 10p15.[17] The 
dysmorphic features of this case do not match the clinical description of another individual 
with a duplication of 9pter[15] In case 5, the 9pter/qter deletion/duplication is considered to 
be causative. The clinical details have been reported elsewhere.[18] In case 6, a de novo 
deletion of the X/Yqter pseudo autosomal region 2 was detected, which was previously also 
described in phenotypically normal individuals (DGV; http://www.tcag.ca/). Therefore, we 
performed an additional SNP array analysis to enable a fairly precise determination of the size 
of the deletion and link it to the severity of the clinical features. To our surprise, this revealed 
a 2 Mb deletion on chromosome 22q11 that has previously been described in patients with a 
similar phenotype.[19] We therefore, conclude that the phenotype of case 6 is not due to the 
de novo X/Yqter deletion, but due to the 22q11 deletion. 
 
Table 1 
Subtelomeric rearrangements found in this study 
 
Table 2 
Clinical features of individuals with subtelomeric rearrangements 
In two cases (case 7 and 8), parental testing showed that the aberration was inherited from an 
unaffected parent. These aberrations were therefore, considered being familial variants that do 
not contribute to the phenotype in case 7 and 8. When parental samples were not available, we 
tried to confirm the presence of the detected subtelomeric aberration using additional 
methodologies [Table 1]. The deletion of the entire Wolf-Hirschhorn Critical Region 
(WHSCR) in 4pter in case 9 was confirmed by MLPA with the SALSA P096 probe kit. 
Furthermore, the clinical features of this patient were consistent with Wolf-Hirschhorn 
Syndrome. In case 10, two duplicated regions of chromosome 22 were identified, one in the 
22q11.2 region (next to the centromere) and the other in the 22q13.3 region (telomere end of 
q arm of chromosome 22). The SALSA P023B probe kit was used to confirm these duplicated 
regions. Two duplications in one arm of the chromosome suggested a complex recombination. 
However, such recombination could not be identified in the routine analysis and warranted 
further characterization. Confirmatory analysis using SNP array showed that both duplications 
actually consisted of 2.6 Mb in 22q11.2 and 1.8 Mb in 22q13.33. Since microduplications of 
both 22q11.2 and 22q13.3 have been associated with highly variable phenotypic 
features,[20,21] we suggest that in case 10, both duplications contribute to the phenotype. 
In cases 11 and 12, a subtelomeric deletion of 9pter was identified. Case 11 showed a milder 
phenotype than previously reported cases.[22,23] In order to see, if the deletion in case 11 
was smaller than the deletions reported before, SNP array analysis was performed. The 
deletion appeared to be 11.8 Mb in size, and it does not exceed the critical region of 9p 
syndrome;[22,23] this, therefore, explained the mild phenotype. In case 12, however, the 
patient showed some similarities to the reported cases.[22] Therefore, it is suggested that 
9pter deletion in case 12 is causative, and array analysis to determine the actual size of the 
deletion was unnecessary. 
In case 13, a microduplication of 15q11 was identified. MLPA analysis of probes in the 
15q11.2-15q15.1 region (MRC Holland kit P028) showed a duplication of the probes between 
breakpoint 1 and breakpoint 3 (including TUBGCP5 and APBA2). The methylation specific 
analysis indicated that the interstitial duplication was of maternal origin. It is suggested, that 
the duplication explains mild ID and minor dysmorphic features in case 13, since duplications 
of 15q11 are associated with a highly variable phenotype.[24] 
In cases 14-20, parental testing and additional testing were not performed. This was due to the 
fact that in some cases, materials for additional testing were unavailable. Another reason was 
that the clinical features of the patient showed some similarities to the reported cases; 
therefore, additional testing was considered unnecessary. In case 14, a subtelomeric deletion 
of 2qter was identified. This patient showed shortening of the metacarpal bones which occurs 
in the majority of 2q37 patients.[25] It is suggested, therefore that the deletion in this case is 
causative. In case 15, a subtelomeric deletion of Xpter and a subtelomeric duplication of 
11pter were identified. The presence of both a deletion and duplication suggests an 
unbalanced translocation. The Xpter probes in the P070 and P036D MLPA kits are both 
located within the SHOX gene. Deletions of this gene are associated with Leri-Weill 
dyschondrosteosis (LWD) and idiopathic short stature (ISS).[26,27] A duplication of 11pter 
has been reported in a case of Silver-Russell syndrome.[28] Therefore, both the dup 11pter 
and the deletion Xpter could be contributing to the short stature of this individual’s 
phenotype. 
In case 16, the subtelomeric deletion of 12pter accompanied by a subtelomeric duplication of 
12qter suggests that the recombinant chromosome resulted from a pericentric inversion in one 
of the parents. Unfortunately, his parents were unavailable to test. Lagier-Tourenne et al. 
(2004) reported two cases of microscopically visible recombinant chromosome 12 and 
reviewed all previously reported cases as well as cases with pure cytogenetic deletion of 
12pter and duplication of 12qter.[29] Compared to these previously reported cases with larger 
abnormalities, our patient showed a milder phenotype such as minor facial dysmorphisms and 
mild ID [Table 2]. It is suggested that the terminal duplication/deletion of chromosome 12 in 
this patient was smaller than previously reported and could contribute to the phenotype. 
In case 17, a subtelomeric deletion of 8pter was identified. He showed mild ID with minor 
facial dysmorphisms. A subtelomeric 8pter deletion is rare, and only few cases have been 
reported.[4] Wu et al. (2010) reported a patient with a very small deletion in terminal 8pter 
with ID, microcephaly and minor facial dysmorphisms. We therefore conclude that the 
clinical features of case 17 are most likely due to the deletion of 8pter. 
In case 18, a duplication of the probes in the SHOX gene in the pseudo-autosomal region 1 
(PAR1) Xpter/Ypter was identified. SHOX duplications limited to PAR1 appear to be rare, 
and the associated phenotype is highly variable.[30,31] SHOX gene defects, either a deletion 
or duplication, were associated with LWD and ISS. It has to be noted; however, that the effect 
of a duplication is ambiguous.[27] Consequently, the clinical features associated with such 
duplication were likely to be under-ascertained.[30] We are uncertain, therefore, whether the 
duplication of this gene contributed to the clinical phenotype or not. 
In cases 19 and 20, a subtelomeric duplication of 16qter was identified. A 16qter 
submicroscopic microduplication is rarely reported. Ravnan et al. (2006) reported five cases 
with a duplication 16qter in which the duplicated signal was adjacent to the 18p subtelomere 
probe signal. In two cases, the recombination appeared to be inherited from unaffected 
parents, and these were considered to be variants. Therefore, in the other three cases the 
recombination was also regarded to be a variant although parental samples were not 
available.[32] It cannot be ruled out; however, that the duplication in cases 19 and 20 are 
contributing to their phenotype since 16qter is a gene-rich region. More than ten genes are 
present in the ~500 kb proximal to 16qter. Some of these (NULP1, TUBB3, and AFG3L1) are 
expressed in the brain,[33] and it is possible that overexpression of these genes contributes to 
ID. 
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Discussion 
This is the first study identifying subtelomeric chromosomal aberrations in Indonesian ID 
individuals. Overall, subtelomeric copy number rearrangements were established in 20 
samples, explaining the phenotype of 16 cases. Therefore, a detection rate of 3.7% (16/436) 
was obtained, of which 31% (5/16) was found to have a complex rearrangement/unbalanced 
translocation, 44% (7/16) had a simple deletion and 25% (4/16) had a simple duplication. In 
addition, the subtelomeric rearrangements contributed as genetic cause of ID in 3% (16/527) 
of cases in the whole cohort. The deletions, including the complex rearrangements, involved 
nine different subtelomeric regions (2q, 4p, 8p, 9p, 10p, 12p, 18p, X/Yp, X/Yq); and 
duplications, including complex rearrangements, involved eight subtelomeric regions (4p, 9p, 
9q, 11p, 12q, 15q11, 22p, X/Yp). 
The detection rate of chromosomal subtelomeric rearrangements in this study is 3.7% 
(16/436) which is well within the range of 2.5% previously reported by Ravnan et al.,[32] and 
4.4% as reported by van Karnebeek et al.[2] Five individuals (5/16; 31%) are suggested to 
have an unbalanced translocation that was not detected by routine cytogenetic analysis. In 
three of these, the translocation was shown to be de novo (case 3, case 4, and case 6), whereas 
in the two others, parental samples were unavailable. The prevalence of these cryptic 
imbalances in our ID population is in the range of a previous study conducted by Wu et al. 
(2010), who reported such rearrangements in 21.7% (5/23) and the study of Jehee et al. 
(2011) which reported such rearrangements in 42.1% (8/19).[6,7] The considerably high rate 
of unbalanced translocations observed in this study might be explained by the fact that we did 
not use high-resolution banding, which could have detected most “cryptic” subtelomeric 
anomalies.[8] 
Although the MLPA method is capable of revealing subtelomeric rearrangements, the clinical 
significance of each rearrangement should be interpreted carefully, particularly for cases in 
which the clinical features are different from previously reported cases. In case 6, for 
example, the de novo subtelomeric X/Yqter deletion could not explain the clinical features 
when compared to the previously reported cases.[32,34] Furthermore, in the DGV it is 
reported that rearrangements in this region can be detected in phenotypically normal 
individuals as well. Subsequent SNP array in this patient identified another abnormality, 
which explained his clinical phenotype. 
To conclude, this is the first large-scale study of the detection of submicroscopic subtelomeric 
aberrations in Indonesian patients with ID. This study shows that subtelomeric 
rearrangements are an important cause of ID in Indonesia, and its prevalence does not differ 
from previously reported studies in the Western world. Since diagnostic facilities for this kind 
of abnormalities are not yet available in Indonesia, the implementation of this technique in a 
routine diagnostic setting will help to establish a genetic diagnosis in individuals with ID, and 
will improve the possibilities for genetic counseling to the families involved. To establish an 
adequate diagnosis is of crucial importance for patients and their families. Therefore, 
diagnostic facilities for genetic diseases need to get a higher priority in Indonesia, similar to 
those for common infectious diseases and nutritional problems. 
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